I just posted to SA:
Thanks Karin; nice piece.
You didn't want to mention it but I will: there will be a presentation at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) to be held in Copenhagen, Denmark from April 25-28, 2015. ECCMID is one of the largest annual gatherings of infectious disease experts in the world, and an ideal forum to present the results of a clinical trial.
This will be the first presentation to a MEDICAL audience to report on the recently completed phase 2b clinical trial of Brilacidin. There should be lots of new eyes of people with insight and money to invest. Shorts beware!
gcharvey